Anas Zayad , Nausheen Ahmed , Zahra Mahmoudjafari , Barry S Skikne , Tara Lin , Muhammad U Mushtaq , Joseph McGuirk , Forat Lutfi , Evguenia Bhurtel , Manisha Bhutani , Faiz Anwar , Omar Alkharabsheh , Atrash Shebli , Al-Ola Abdallah
{"title":"The Impact of Sponsors on Development of Clinical Research in Multiple Myeloma and AL Amyloidosis: An In-Depth Analysis","authors":"Anas Zayad , Nausheen Ahmed , Zahra Mahmoudjafari , Barry S Skikne , Tara Lin , Muhammad U Mushtaq , Joseph McGuirk , Forat Lutfi , Evguenia Bhurtel , Manisha Bhutani , Faiz Anwar , Omar Alkharabsheh , Atrash Shebli , Al-Ola Abdallah","doi":"10.1016/j.clml.2025.04.019","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"25 8","pages":"Pages e600-e603"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma, Myeloma & Leukemia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2152265025001491","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.